Corindus Vascular Robotics to Report Third Quarter 2016 Financial Results on November 8, 2016 | Business Wire

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer

of precision vascular robotics, today announced that it'll

release financial and business results for the third quarter 2016 after

the close of trading on Tuesday, November 8, 2016. The Company’s

management team will host a corresponding conference call beginning at

4:30 p.m. ET to discuss the financial results and recent business

developments.

Investors interested in listening to the conference call may do so by

Recent Developments in Coatings – Research and Markets | Business Wire

DUBLIN--(BUSINESS WIRE)--The "Recent Developments in Coatings" report has been added to Research and Markets' offering.

This issue of the Advanced Coatings and Surface Technology TOE profiles research studies related to the development of water repellant and anti-fouling coatings.

The issue also profiles innovations focused on water borne coatings that are commercialized for use in extreme temperature and operating conditions and also a composite coating intended for metal substrates.

The Advanced Coating & Surface Technology TechVision Opportunity Engine (TOE) provides intelligence on technologies, products, processes, applications and strategic insights on various coatings across industries.

This encompasses protective and functional coatings such as antimicrobial coatings, food coatings, energy-saving coatings, smart glazing, hydrophilic, hydrophobic and super hydrophobic coatings, corrosion protection coatings, barrier coatings and paints.

The Chemicals and Advanced Materials cluster tracks research & innovation trends and developments across specialty chemicals, plastics, polymers, chemicals, bio-chemicals, metals, coatings, thin films,...

dialling (877) 201-0168 for domestic callers or (647) 788-4901 for

international callers (Conference ID: 97286733). From the webcast on

the “Investor Relations” section of the Company’s website at: www.corindus.com.

Following the call, an audio replay will be available on the Investor

Relations section of the Company’s website.

About Corindus Vascular Robotics, Inc.

Corindus

Vascular Robotics, Inc. is a global technology leader in

robotic-assisted vascular interventions. The company’s CorPath®

System is the first FDA-cleared medical device to bring robotic-assisted

precision to radial, coronary and peripheral procedures. During the

procedure, the interventional cardiologist sits at a radiation-shielded

workstation to advance stents and guidewires with

millimeter-by-millimeter precision. The workstation allows the physician

greater control and the freedom from wearing heavy lead protective

equipment that causes musculoskeletal injuries. With the CorPath System,

Corindus Vascular Robotics brings robotic precision to radial and

complex interventional procedures to help optimize clinical outcomes and

minimize the costs associated with complications of improper stent

placement with manual procedures. Corindus stands behind its product

with its unique $1,000 hospital credit “One Stent Program.”

For additional information, visit www.corindus.com,

and follow @CorindusInc.